{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:13:43Z","timestamp":1793373223935,"version":"4.5.0"},"reference-count":132,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00777","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T01:29:00Z","timestamp":1555378140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":100,"title":["A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity)"],"prefix":"10.3389","volume":"10","author":[{"given":"Irbaz Bin","family":"Riaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warda","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini S.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","article-title":"Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007","volume":"34","author":"Kobrynski","year":"2014","journal-title":"J Clin Immunol."},{"key":"B2","first-page":"5465s","article-title":"Primary immunodeficiencies: genetic risk factors for lymphoma","volume":"52","author":"Filipovich","year":"1992","journal-title":"Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2015\/123548","article-title":"Non-Hodgkin lymphoma in children with primary immunodeficiencies: clinical manifestations, diagnosis, and management, belarusian experience","volume":"2015","author":"Fedorova","year":"2015","journal-title":"Lymphoma."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clml.2012.06.005","article-title":"Combating cancer predisposition in association with idiopathic immune deficiency: a recurrent nodal and cutaneous T-cell lymphoproliferative disease in a patient with cartilage-hair hypoplasia","volume":"13","author":"Taskinen","year":"2013","journal-title":"Clin Lymph Myeloma Leuk."},{"key":"B6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3324\/haematol.2017.169987","article-title":"Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature","volume":"103","author":"Nijland","year":"2018","journal-title":"Haematologica."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","article-title":"Autoimmunity and primary immunodeficiency: two sides of the same coin?","volume":"14","author":"Schmidt","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: update and perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/MMBR.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol Mol Biol Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol."},{"key":"B11","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2013.01.042","article-title":"Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation","volume":"131","author":"Moshous","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/ajmg.a.31644","article-title":"Epstein\u2013Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome","author":"Toita","year":"2007","journal-title":"Am J Med Genet A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1172\/JCI16774","article-title":"Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis","volume":"111","author":"Moshous","year":"2003","journal-title":"J Clin Investig."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"New Engl J Med."},{"key":"B17","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.4049\/jimmunol.176.8.5060","article-title":"A severe form of human combined immunodeficiency due to mutations in DNA ligase IV","volume":"176","author":"Enders","year":"2006","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaci.2010.09.016","article-title":"Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency","volume":"127","author":"Newell","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0022-3476(86)80892-7","article-title":"Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow","volume":"108","author":"Kapoor","year":"1986","journal-title":"J Pediatr."},{"key":"B20","first-page":"1145","article-title":"Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations","volume":"135","author":"Ratech","year":"1989","journal-title":"Am J Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.jaci.2004.12.626","article-title":"Case report: cerebral lymphoma in an ADA-deficient SCID patient receiving PEG-ADA","volume":"115","author":"Kaufman","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpeds.2007.03.059","article-title":"Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase","volume":"151","author":"Husain","year":"2007","journal-title":"J Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/ped.2014.0478","article-title":"Adenosine deaminase-deficient severe combined immunodeficiency and diffuse large B-cell lymphoma","volume":"28","author":"Genel","year":"2015","journal-title":"Pediatr AllergyImmunol Pulmonol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","article-title":"First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature","volume":"9","author":"Migliavacca","year":"2018","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J Clin Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/MPH.0b013e31829f3496","article-title":"Epstein-barr virus-associated extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma) arising in the parotid gland of a child with ataxia telangiectasia","volume":"37","author":"Bennett","year":"2015","journal-title":"J Pediatr Hematol Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/pbc.25621","article-title":"Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab","volume":"62","author":"Meister","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/bmt.2016.93","article-title":"Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma","volume":"51","author":"Beier","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2350\/10-01-0787-CR.1","article-title":"Hodgkin's and non-Hodgkin's lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature","volume":"14","author":"Du","year":"2011","journal-title":"Pediatr Devel Pathol."},{"key":"B30","first-page":"48","article-title":"Burkitt lymphoma-induced ileocolic intussusception in Wiskott-Aldrich syndrome","volume":"28","author":"Pasic","year":"2006","journal-title":"J Pediatr Hematol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0165-5876(03)00155-1","article-title":"Malignant B cell non-Hodgkin's lymphoma of the larynx in children with Wiskott Aldrich syndrome","volume":"67","author":"Palenzuela","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1651-2227.2001.tb01589.x","article-title":"Epstein-Barr virus-associated Hodgkin's disease in a patient with Wiskott-Aldrich syndrome","volume":"90","author":"Sasahara","year":"2001","journal-title":"Acta Paediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/1097-0142(19930815)72:4<1376::AID-CNCR2820720437>3.0.CO;2-Q","article-title":"Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome","volume":"72","author":"Nakanishi","year":"1993","journal-title":"Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/hon.2900110304","article-title":"Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome","volume":"11","author":"Gulley","year":"1993","journal-title":"Hematol Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/adc.81.5.444","article-title":"B cell non-Hodgkin's lymphoma in a girl with the DiGeorge anomaly","volume":"81","author":"Ramos","year":"1999","journal-title":"Arch Dis Childhood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","article-title":"Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma","author":"Taskinen","year":"2008","journal-title":"Am J Med Genet Part A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/pbc.21789","article-title":"Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS)","volume":"52","author":"Dembowska-Baginska","year":"2009","journal-title":"Pediatr Blood Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-2141.2011.08863.x","article-title":"Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey","volume":"155","author":"Bienemann","year":"2011","journal-title":"Br J Haematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/carcin\/bgl126","article-title":"Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein","volume":"28","author":"Kruger","year":"2007","journal-title":"Carcinogenesis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/path.2418","article-title":"Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation","volume":"216","author":"Gladkowska-Dura","year":"2008","journal-title":"J Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<536::AID-MPO3>3.0.CO;2-Z","article-title":"Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials","volume":"33","author":"Seidemann","year":"1999","journal-title":"Medic Pediatr Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3816\/CLM.2007.n.046","article-title":"Successful treatment of diffuse large B-cell non-hodgkin lymphoma with modified CHOP (cyclophosphamide\/doxorubicin\/vincristine\/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndrome","volume":"7","author":"Dumic","year":"2007","journal-title":"Clin Lymph Myeloma."},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MPH.0b013e318190d72c","article-title":"Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome","volume":"31","author":"Jovanovic","year":"2009","journal-title":"J Pediatr Hematol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clim.2010.01.008","article-title":"Nijmegen breakage syndrome: Long-term monitoring of viral and immunological biomarkers in peripheral blood before development of malignancy","volume":"135","author":"Gregorek","year":"2010","journal-title":"Clin Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","article-title":"Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options - a retrospective analysis","volume":"35","author":"Wolska-Kusnierz","year":"2015","journal-title":"J Clin Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1468-3083.2003.00585.x","article-title":"Dyskeratosis congenita associated with three malignancies","volume":"17","author":"Baykal","year":"2003","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B47","first-page":"222","article-title":"Non-hodgkin lymphoma in a child with schimke immuno-osseous dysplasia","volume":"36","author":"Basiratnia","year":"2011","journal-title":"Iran J Med Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/ajmg.a.35532","article-title":"SMARCAL1 deficiency predisposes to non-Hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo","author":"Baradaran-Heravi","year":"2012","journal-title":"Am J Med Genet Part A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ajmg.a.30356","article-title":"Fatal lymphoproliferative disorder in a child with Schimke immuno-osseous dysplasia","volume":"131","author":"Taha","year":"2004","journal-title":"Am J Med Genet Part A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/ICO.0b013e31806c77d6","article-title":"CHARGE association, hyper-immunoglobulin M syndrome, and conjunctival MALT lymphoma","volume":"26","author":"Fuentes-P\u00e1ez","year":"2007","journal-title":"Cornea."},{"key":"B51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaci.2014.02.020","article-title":"Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome","volume":"134","author":"Kracker","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science."},{"key":"B54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archinte.1982.00340140092017","article-title":"Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patients","volume":"142","author":"Gelmann","year":"1982","journal-title":"Arch Int Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/10428190500285285","article-title":"Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency","volume":"47","author":"Aghamohammadi","year":"2006","journal-title":"Leukemia Lymph."},{"key":"B57","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1046\/j.1365-2222.2001.01117.x","article-title":"Current perspectives on common variable immunodeficiency (CVID)","volume":"31","author":"Spickett","year":"2001","journal-title":"Clin Exp Allergy."},{"key":"B58","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00043426-198722000-00017","article-title":"The immunodeficiency cancer registry","volume":"9","author":"Filipovich","year":"1987","journal-title":"Am J Pediatr Hematol Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(85)91037-2","article-title":"Prospective study of cancer in patients with hypogammaglobulinaemia","volume":"1","author":"Kinlen","year":"1985","journal-title":"Lancet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2249.2003.02253.x","article-title":"Lymphoproliferative disease in antibody deficiency: a multi-centre study","volume":"134","author":"Gompels","year":"2003","journal-title":"Clin Exp Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40364-016-0061-8","article-title":"Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma","volume":"4","author":"Rael","year":"2016","journal-title":"Biomarker Res."},{"key":"B62","first-page":"315","volume-title":"Inmunodeficiencia Com\u00fan Variable: Epidemiolog\u00eda y Manifestaciones Cl\u00ednicas en 69 Pacientes.","author":"Fern\u00e1ndez","year":"2013"},{"key":"B63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajh.10050","article-title":"Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency","volume":"69","author":"Cunningham-Rundles","year":"2002","journal-title":"Am J Hematol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ajh.2830370202","article-title":"Non-Hodgkin lymphoma in common variable immunodeficiency","volume":"37","author":"Cunningham-Rundles","year":"1991","journal-title":"Am J Hematol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF00915550","article-title":"Incidence of cancer in 98 patients with common varied immunodeficiency","volume":"7","author":"Cunningham-Rundles","year":"1987","journal-title":"J Clin Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/BF01315216","article-title":"Jejunal lymphoma in a patient with primary adult-onset hypogammaglobulinemia and nodular lymphoid hyperplasia of the small intestine","volume":"25","author":"Lamers","year":"1980","journal-title":"Digest Dis Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1097-0142(19820201)49:3<445::AID-CNCR2820490309>3.0.CO;2-1","article-title":"Immunoblastic lymphoma of small intestine complicating late-onset immunodeficiency","volume":"49","author":"Gonzalez-Vitale","year":"1982","journal-title":"Cancer."},{"key":"B69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004836-199209000-00010","article-title":"Malignant lymphoma of jejunum with common variable hypogammaglobulinemia and diffuse nodular hyperplasia of the small intestine","volume":"15","author":"Castellano","year":"1992","journal-title":"J Clin Gastroenterol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol."},{"key":"B71","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Quart J Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000050475","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome","volume":"68","author":"Reichenberger","year":"2001","journal-title":"Respiration."},{"key":"B73","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/cup.12230","article-title":"Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency","volume":"40","author":"Wobser","year":"2013","journal-title":"J Cutaneous Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"245893","DOI":"10.1155\/2013\/245893","article-title":"Autoimmune lymphoproliferative syndrome and epstein-barr virus-associated lymphoma: an adjunctive diagnostic role for monitoring EBV viremia?","volume":"2013","author":"Pace","year":"2013","journal-title":"Case Rep Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1097\/MPH.0000000000000815","article-title":"Novel mutations in SH2D1A gene in X-linked lymphoproliferative syndrome, diagnosed after B-cell non-hodgkin lymphoma","volume":"39","author":"Sharapova","year":"2017","journal-title":"J Pediatr Hematol Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00431-006-0290-1","article-title":"Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease","volume":"166","author":"Hugle","year":"2007","journal-title":"Eur J Pediatr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/1097-0142(19920801)70:3<683::AID-CNCR2820700324>3.0.CO;2-C","article-title":"Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease","volume":"70","author":"Egeler","year":"1992","journal-title":"Cancer."},{"key":"B80","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/MPH.0000000000000366","article-title":"Atypical clinical course in pediatric hodgkin lymphoma: association with germline mutations in interleukin-2-inducible T-cell kinase","volume":"37","author":"Alme","year":"2015","journal-title":"J Pediatr Hematol Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/pbc.25648","article-title":"ITK deficiency: how can EBV be treated before lymphoma?","volume":"62","author":"Cipe","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clim.2014.01.007","article-title":"Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders","volume":"151","author":"Shamriz","year":"2014","journal-title":"Clin Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/leu.2011.371","article-title":"Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases","volume":"26","author":"Linka","year":"2012","journal-title":"Leukemia."},{"key":"B84","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3324\/haematol.2010.033910","article-title":"IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach","volume":"96","author":"Stepensky","year":"2011","journal-title":"Haematologica."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Investig."},{"key":"B86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20160784","article-title":"Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection","volume":"214","author":"Izawa","year":"2017","journal-title":"J Exp Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","article-title":"Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency","volume":"214","author":"Abolhassani","year":"2017","journal-title":"J Exp Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaci.2015.02.022","article-title":"Novel mutations in TNFRSF7\/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency","volume":"136","author":"Alkhairy","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","article-title":"XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood."},{"key":"B90","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science."},{"key":"B91","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","article-title":"Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease","volume":"35","author":"Dhalla","year":"2015","journal-title":"J Clin Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","article-title":"A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease","volume":"159","author":"Patiroglu","year":"2015","journal-title":"Clin Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nature13386","article-title":"CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation","volume":"510","author":"Martin","year":"2014","journal-title":"Nature."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1182\/blood-2013-06-508267","article-title":"A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency","volume":"122","author":"Neven","year":"2013","journal-title":"Blood."},{"key":"B95","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mjd.2001.111337","article-title":"B-cell lymphoma in a patient with WHIM syndrome","volume":"44","author":"Chae","year":"2001","journal-title":"J Am Acad Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00277-002-0489-9","article-title":"Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis","volume":"81","author":"Imashuku","year":"2002","journal-title":"Ann Hematol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1097-0142(19870115)59:2<271::AID-CNCR2820590216>3.0.CO;2-H","article-title":"Common variable hypogammaglobulinemia complicated by an unusual T-suppressor\/cytotoxic cell lymphoma","volume":"59","author":"Durham","year":"1987","journal-title":"Cancer."},{"key":"B98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0002-9343(88)90519-0","article-title":"Peripheral T-cell lymphoma complicating common variable hypogammaglobulinemia","volume":"85","author":"Kim","year":"1988","journal-title":"Am J Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/10428199909058418","article-title":"Peripheral T cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review","volume":"32","author":"Gottesman","year":"1999","journal-title":"Leukemia Lymphoma."},{"key":"B100","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00000478-199804000-00017","article-title":"Abdominal T-cell non-Hodgkin's lymphoma of the gamma\/delta type in a patient with selective immunoglobulin A deficiency","volume":"22","author":"Ott","year":"1998","journal-title":"Am J Surg Pathol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/10428190109097697","article-title":"Extranodal cytotoxic T-cell lymphoma in a patient with X-linked agammaglobulinaemia","volume":"42","author":"Kanavaros","year":"2001","journal-title":"Leukemia Lymphoma"},{"key":"B102","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jaad.2014.03.028","article-title":"CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency","volume":"71","author":"Gammon","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B103","first-page":"Ecr27","article-title":"T-cell lymphoblastic leukemia\/lymphoma in Nijmegen breakage syndrome","volume":"89","author":"Pasic","year":"2004","journal-title":"Haematologica."},{"key":"B104","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3324\/haematol.2012.068791","article-title":"Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27","volume":"98","author":"Salzer","year":"2013","journal-title":"Haematologica."},{"key":"B105","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4049\/jimmunol.149.9.3107","article-title":"Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiency","volume":"149","author":"Hirschhorn","year":"1992","journal-title":"J Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/CMAR.S50497","article-title":"DNA repair in cancer: emerging targets for personalized therapy","volume":"6","author":"Abbotts","year":"2014","journal-title":"Cancer Manage Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","article-title":"X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options","volume":"115","author":"Albert","year":"2010","journal-title":"Blood."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.4049\/jimmunol.1701007","article-title":"SAP and lessons learned from a primary immunodeficiency","volume":"199","author":"Cannons","year":"2017","journal-title":"J Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/MPG.0000000000000532","article-title":"Large B-cell lymphoma in an adolescent patient with interleukin-10 receptor deficiency and history of infantile inflammatory bowel disease","volume":"63","author":"Shouval","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1182\/blood-2013-10-531657","article-title":"No immunosurveillance in human IL-10R deficiency","volume":"122","author":"Oft","year":"2013","journal-title":"Blood."},{"key":"B112","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J Aller Clin Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06322.x","article-title":"DNA repair: the link between primary immunodeficiency and cancer","volume":"1246","author":"de Miranda","year":"2011","journal-title":"Ann NY Acad Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMra1703366","article-title":"Monogenic diseases of DNA repair","volume":"377","author":"Keijzers","year":"2017","journal-title":"N Engl J Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.critrevonc.2016.10.014","article-title":"Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders","volume":"108","author":"Shabani","year":"2016","journal-title":"Crit Rev Oncol Hematol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3389\/fimmu.2018.01103","article-title":"Inherited immunodeficiencies with high predisposition to Epstein-Barr virus-driven lymphoproliferative diseases","volume":"9","author":"Latour","year":"2018","journal-title":"Front Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/eji.201242852","article-title":"T-cell exhaustion due to persistent antigen: quantity not quality?","volume":"42","author":"Zuniga","year":"2012","journal-title":"Eur J Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.seminoncol.2014.09.004","article-title":"Mechanism of action of immunotherapy","volume":"41","author":"Disis","year":"2014","journal-title":"Semin Oncol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jama.2018.13995","article-title":"Immune checkpoint inhibitor toxicity in 2018","volume":"320","author":"Johnson","year":"2018","journal-title":"JAMA."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/gcc.22249","article-title":"Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma","volume":"54","author":"Yoon","year":"2015","journal-title":"Genes Chromosomes Cancer."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000350493","article-title":"Genetic and immunohistochemical characterization of Epstein-Barr virus-associated diffuse large B-cell lymphoma","volume":"131","author":"Al-Humood","year":"2014","journal-title":"Acta Haematol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2014-08-551598","article-title":"How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus","volume":"125","author":"Uldrick","year":"2015","journal-title":"Blood."},{"key":"B125","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbmt.2017.11.019","article-title":"Outcomes after allogeneic transplant in patients with Wiskott-Aldrich syndrome","volume":"24","author":"Ngwube","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B129","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1182\/blood-2017-09-807487","article-title":"Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency","volume":"131","author":"Fox","year":"2018","journal-title":"Blood."},{"key":"B130","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2018.02.007","article-title":"Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy","volume":"190","author":"Verhoeven","year":"2018","journal-title":"Clin Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3389\/fimmu.2018.02912","article-title":"Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: the perspective of an interdisciplinary working group","volume":"9","author":"Bomken","year":"2018","journal-title":"Front Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00777\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T15:45:23Z","timestamp":1694792723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00777\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":132,"alternative-id":["10.3389\/fimmu.2019.00777"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00777","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"article-number":"777"}}